| First Author | Rubin EM | Year | 1991 |
| Journal | J Clin Invest | Volume | 87 |
| Issue | 2 | Pages | 639-47 |
| PubMed ID | 1991848 | Mgi Jnum | J:136653 |
| Mgi Id | MGI:3796738 | Doi | 10.1172/JCI115041 |
| Citation | Rubin EM, et al. (1991) Hypoxia-induced in vivo sickling of transgenic mouse red cells. J Clin Invest 87(2):639-47 |
| abstractText | To develop an animal model for sickle cell anemia, we have created transgenic mice that express a severe naturally occurring human sickling hemoglobin, Hb S Antilles. Due to its low solubility and oxygen affinity, Hb S Antilles has a greater propensity to cause red cell sickling than Hb S. To make transgenic animals that express a high level of Hb S Antilles, the erythroid-specific DNAse I hypersensitive site II from the human beta-globin cluster was linked independently to the human alpha 2-globin gene and to the beta S Antilles gene. Embryos were injected with both constructs simultaneously and seven transgenic mice were obtained, three of which contained both the human alpha and the human beta S Antilles transgene. After crossing the human transgenes into the mouse beta-thalassemic background a transgenic mouse line was derived in which approximately half the beta-globin chains in the murine red cells were human beta S Antilles. Deoxygenation of the transgenic red cells in vitro resulted in extensive sickling. An increase of in vivo sickling was achieved by placing these transgenic mice in a low oxygen environment. This murine model for red cell sickling should help to advance our understanding of sickle cell disease and may provide a model to test therapeutic interventions. |
